Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes
Open Access
- 28 June 2012
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 87 (11), 1006-1009
- https://doi.org/10.1002/ajh.23303
Abstract
We hypothesized that hypoalbuminemia is an independent prognostic factor in patients with myelodysplastic syndromes (MDS). We analyzed records of 767 patients treated at Moffitt Cancer Center between January 2001 and December 2009 to evaluate the relationship between serum albumin (SA) at the time of presentation and overall survival (OS). Patients (median age of 69 years) were stratified into three groups based on SA concentration (≤3.5, 3.6–4.0, and >4.0 g/dL). Two‐thirds of the patients had low or intermediate‐1 International Prognostic Scoring System (IPSS)‐based risk for MDS. Median OS by SA concentration of ≤3.5, 3.6–4.0, and >4.0 g/dL was 11, 23, and 34 months, respectively (P < 0.005), whereas rate of acute myeloid leukemia progression was highest in patients with low SA (≤3.5 g/dL). The SA level offered prognostic discrimination for outcomes within the lower and higher IPSS risk groups, as well as with the MD Anderson risk model. In multivariable analysis, SA was a significant independent co‐variate for OS after adjustment for IPSS, age, serum ferritin, and transfusion dependence (hazard ratio = 0.8; 95% CI 0.6–0.9; P = 0.004). Our findings indicate that hypoalbuminemia is an independent prognostic biomarker that may serve as a surrogate representative of disease biology or comorbidities in patients with MDS. Am. J. Hematol., 2012.Keywords
This publication has 21 references indexed in Scilit:
- Severe Hypoalbuminemia at Day 90 Predicts Worse Nonrelapse Mortality and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic SyndromeTransplantation and Cellular Therapy, 2011
- Low preoperative serum albumin in colon cancer: a risk factor for poor outcomeInternational Journal of Colorectal Disease, 2010
- Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromesHaematologica, 2010
- Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndromeHaematologica, 2010
- ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemiaBritish Journal of Haematology, 2010
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid MalignanciesCancer Research, 2008
- Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromesPublished by Elsevier BV ,2008
- Signalling and survival pathways in multiple myelomaEuropean Journal Of Cancer, 2006
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysisCancer, 1993